Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03428945
Recruitment Status : Recruiting
First Posted : February 12, 2018
Last Update Posted : August 15, 2019
Sponsor:
Collaborator:
Juvenile Diabetes Research Foundation
Information provided by (Responsible Party):
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2024
Estimated Study Completion Date : August 2024